RECURRENT GLIOBLASTOMA MULTIFORME
Clinical trials for RECURRENT GLIOBLASTOMA MULTIFORME explained in plain language.
Never miss a new study
Get alerted when new RECURRENT GLIOBLASTOMA MULTIFORME trials appear
Sign up with your email to follow new studies for RECURRENT GLIOBLASTOMA MULTIFORME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Belly fat graft could outsmart brain Cancer's defenses
Disease control Recruiting nowThis early study tests if a piece of belly tissue placed in the brain during surgery can safely bypass the blood-brain barrier in people with recurrent glioblastoma, an aggressive brain cancer. Ten adults will be followed for 6 months to check for side effects like rapid tumor gr…
Matched conditions: RECURRENT GLIOBLASTOMA MULTIFORME
Phase: NA • Sponsor: Northwell Health • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Immune cells engineered to attack brain tumors enter human testing
Disease control Recruiting nowThis early-stage trial tests a new treatment for adults with a returning, aggressive brain cancer called glioblastoma. The therapy uses the patient's own immune cells, modified to recognize and attack the cancer, and delivers them directly into the brain. The main goals are to se…
Matched conditions: RECURRENT GLIOBLASTOMA MULTIFORME
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New drug combo takes on deadly brain tumors
Disease control Recruiting nowThis early-stage study tests an experimental drug called AZD1390 combined with radiation therapy for people with glioblastoma or brain metastases. The main goal is to check safety and find the best dose. About 180 participants will receive different doses of AZD1390 alongside rad…
Matched conditions: RECURRENT GLIOBLASTOMA MULTIFORME
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC